Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

IPC Welcomes Oruka Therapeutics as a 2025 Bronze Level Corporate Member

We’re excited to announce that Oruka Therapeutics has joined the International Psoriasis Council as a 2025 Bronze Level Corporate Member. Oruka is a pioneering biopharmaceutical company advancing potentially best-in-class monoclonal antibody therapies for plaque psoriasis, psoriatic arthritis, and related inflammatory skin conditions. Their seasoned team of biopharma professionals is dedicated to improving patient experiences through innovative biologic treatments.

“We’re delighted to welcome Oruka into the IPC community,” said IPC CEO Christy Langan. “Their focus on developing targeted antibody therapies will deepen our collective understanding of psoriasis biology and support our goal of improving care for people living with this disease.”

Please join us in extending a warm welcome to Oruka.

Learn more about Oruka Therapeutics.

Categories

Recent Posts

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

VIEW

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

VIEW

Reframing Obesity in Psoriatic Disease: From Pharmacokinetic Barrier to Therapeutic Target

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026